Capmatinib
Product Specifications
CAS Number
1029712-80-8
Target
C-Met/HGFR, Apoptosis
Related Pathways
Tyrosine Kinase/Adaptors, Apoptosis
Purity
0.9976
Bioactivity
Capmatinib (INCB28060) is an orally bioavailable inhibitor of the proto-oncogene c-Met (HGFR) with potential antineoplastic activity.
Smiles
CNC(=O)c1ccc(cc1F)-c1cnc2ncc(Cc3ccc4ncccc4c3)n2n1
Molecular Formula
C23H17FN6O
Molecular Weight
412.42
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1295650-01 0.5 mg (E-Coli)
Recombinant Plasmodium falciparum STI1-like protein (PF14_0324), partial
Sign In for Pricing
View Details MBS1295650-02 0.05 mg (Baculovirus)
Recombinant Plasmodium falciparum STI1-like protein (PF14_0324), partial
Sign In for Pricing
View Details MBS1295650-03 0.05 mg (Mammalian-Cell)
Recombinant Plasmodium falciparum STI1-like protein (PF14_0324), partial
Sign In for Pricing
View Details MBS1295650-04 0.5 mg (Yeast)
Recombinant Plasmodium falciparum STI1-like protein (PF14_0324), partial
Sign In for Pricing
View Details MBS1295650-05 1 mg (E-Coli)
Recombinant Plasmodium falciparum STI1-like protein (PF14_0324), partial
Sign In for Pricing
View Details